PubRank

William J Bellini

Author PubWeight™ 158.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003 29.55
2 Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003 18.34
3 Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 2006 3.65
4 Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 2004 3.23
5 Recent resurgence of mumps in the United States. N Engl J Med 2008 2.90
6 Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004 2.88
7 Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis 2005 2.62
8 Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis 2011 2.03
9 Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis 2012 1.98
10 Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J Virol 2005 1.77
11 Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 2004 1.76
12 Seroprevalence of antibody to mumps virus in the US population, 1999-2004. J Infect Dis 2010 1.70
13 Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003 1.49
14 Measles outbreak associated with an international youth sporting event in the United States, 2007. Pediatr Infect Dis J 2010 1.49
15 Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J Virol Methods 2005 1.48
16 Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One 2008 1.48
17 The C protein of measles virus inhibits the type I interferon response. Virology 2003 1.47
18 Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approaches. Virus Res 2003 1.43
19 Molecular epidemiology of measles viruses in the United States, 1997-2001. Emerg Infect Dis 2002 1.43
20 Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012 1.40
21 Measles - United States, January 1-May 23, 2014. MMWR Morb Mortal Wkly Rep 2014 1.40
22 Update on the global distribution of genotypes of wild type measles viruses. J Infect Dis 2003 1.36
23 A world without measles. J Infect Dis 2011 1.35
24 Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog 2008 1.27
25 Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004. J Infect Dis 2007 1.27
26 Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008 1.26
27 Detection of measles virus RNA in whole blood stored on filter paper. J Med Virol 2002 1.25
28 Nipah virus conforms to the rule of six in a minigenome replication assay. J Gen Virol 2004 1.25
29 Molecular epidemiology of measles viruses in China, 1995-2003. Virol J 2007 1.20
30 Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis 2011 1.17
31 Genetic homogeneity of measles viruses associated with a measles outbreak, São Paulo, Brazil, 1997. Emerg Infect Dis 2002 1.15
32 Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010. Emerg Infect Dis 2012 1.14
33 Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 2008 1.14
34 Measles outbreak in the Republic of the Marshall Islands, 2003. Int J Epidemiol 2005 1.14
35 Genetic analysis of measles viruses isolated in the united states between 1989 and 2001: absence of an endemic genotype since 1994. J Infect Dis 2004 1.14
36 Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J Clin Microbiol 2007 1.13
37 Functional properties of the fusion and attachment glycoproteins of Nipah virus. Virology 2002 1.12
38 Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008 1.11
39 Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. J Infect Dis 2008 1.09
40 Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010. Pediatr Infect Dis J 2013 1.07
41 Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay. J Virol 2002 1.04
42 Single endemic genotype of measles virus continuously circulating in China for at least 16 years. PLoS One 2012 1.03
43 SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis 2004 1.03
44 Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology 2005 1.02
45 Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol 2008 1.02
46 Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons. Virology 2010 1.01
47 Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis 2011 1.00
48 The C, V and W proteins of Nipah virus inhibit minigenome replication. J Gen Virol 2008 1.00
49 Persistence of vaccine-induced antibody to measles 26-33 years after vaccination. J Infect Dis 2004 0.99
50 Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. J Virol Methods 2005 0.99
51 Improving molecular tools for global surveillance of measles virus. J Clin Virol 2013 0.98
52 Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J Infect Dis 2004 0.98
53 Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells. J Gen Virol 2009 0.98
54 Comparison of available methods to elute serum from dried blood spot samples for measles serology. J Virol Methods 2006 0.97
55 Improving global virologic surveillance for measles and rubella. J Infect Dis 2011 0.97
56 SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Res 2005 0.96
57 Development of a neutralization assay for Nipah virus using pseudotype particles. J Virol Methods 2009 0.96
58 DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. Virology 2003 0.96
59 Measles resurgence associated with continued circulation of genotype H1 viruses in China, 2005. Virol J 2009 0.96
60 Evaluation of the measles clinical case definition. J Infect Dis 2004 0.95
61 Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. J Infect Dis 2004 0.94
62 Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clin Infect Dis 2014 0.92
63 Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response. PLoS One 2012 0.92
64 Lack of evidence of measles virus shedding in people with inapparent measles virus infections. J Infect Dis 2004 0.92
65 New measles genotype, Uganda. Emerg Infect Dis 2005 0.91
66 Genetic characterization of measles viruses isolated in Turkey during 2000 and 2001. Virol J 2005 0.91
67 Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol 2012 0.91
68 Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals. J Infect Dis 2011 0.91
69 Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method. Clin Vaccine Immunol 2013 0.89
70 Cell culture and electron microscopy for identifying viruses in diseases of unknown cause. Emerg Infect Dis 2013 0.89
71 Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009. Clin Vaccine Immunol 2013 0.89
72 Viruses detected among sporadic cases of parotitis, United States, 2009-2011. J Infect Dis 2013 0.89
73 Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi. J Infect Dis 2011 0.89
74 Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003. Bull World Health Organ 2009 0.89
75 Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 2007 0.88
76 A new complication of stem cell transplantation: measles inclusion body encephalitis. Pediatrics 2004 0.88
77 Characterization of measles sequences from Pune, India. J Med Virol 2002 0.88
78 Expansion of the global measles and rubella laboratory network 2005-09. J Infect Dis 2011 0.88
79 Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci 2011 0.88
80 Incremental effectiveness of 2 doses of measles-containing vaccine compared with 1 dose among high school students during an outbreak. J Infect Dis 2004 0.87
81 Population immunity to measles in the United States, 1999. J Infect Dis 2004 0.85
82 Genetic analysis of measles viruses isolated in Morocco. J Med Virol 2002 0.85
83 Genetic and antigenic characterization of measles viruses that circulated in Korea during the 2000-2001 epidemic. J Med Virol 2003 0.85
84 Genetic characterization of wild-type measles viruses isolated in China, 2006-2007. Virol J 2010 0.84
85 Adaptation to cell culture induces functional differences in measles virus proteins. Virol J 2008 0.84
86 Genetic characterization of the hemagglutinin genes of wild-type measles virus circulating in china, 1993-2009. PLoS One 2013 0.84
87 Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol 2010 0.83
88 Contribution of dendritic cells to measles virus induced immunosuppression. Rev Med Virol 2012 0.83
89 The genomic termini of wild-type and vaccine strains of measles virus. Virus Res 2006 0.82
90 Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine. Vaccine 2004 0.81
91 Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins. Clin Vaccine Immunol 2012 0.81
92 Genetic characterization of Chinese measles vaccines by analysis of complete genomic sequences. J Med Virol 2009 0.81
93 Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial. J Infect Dis 2003 0.78
94 Edmonston measles virus prevents increased cell surface expression of peptide-loaded major histocompatibility complex class II proteins in human peripheral monocytes. J Virol 2003 0.78
95 Guidance for isolation precautions for mumps in the United States: a review of the scientific basis for policy change. Clin Infect Dis 2010 0.78
96 A 29-year-old pregnant woman with worsening left hemiparesis, encephalopathy, and hemodynamic instability: a case report of subacute sclerosing panencephalitis. Clin Neuropathol 2015 0.77
97 Mumps surveillance and prevention: putting mumps back on our radar screen. Cleve Clin J Med 2007 0.77
98 Measles immunization coverage determined by serology and immunization record from children in two Chicago communities. Public Health Rep 2006 0.76
99 Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination. Vaccine 2013 0.75
100 Congenital and neonatal measles during an epidemic in São Paulo, Brazil in 1997. Pediatr Infect Dis J 2005 0.75